Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30383135.
- Also identified by DOI 10.1001/jamaoncol.2018.5090 and PMC identifier 6440708.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This retrospective observational analysis of health claims data compares the safety, effectiveness, and cost of biosimilar filgrastim and filgrastim.
Medical subject headings
- Biosimilar Pharmaceuticals
- Chemotherapy-Induced Febrile Neutropenia
- Intercellular Signaling Peptides and Proteins
- Neoplasms
- Palliative Care